On Monday, China's National Health Commission downgraded COVID-19 to Class B infectious disease, meaning management measures will change accordingly. What to make of this policy change? Four medical experts from China, Korea, the United States and Denmark give their analysis.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3